Wednesday, July 29, 2020
A common diabetes medication may slow memory decline in Alzheimer's disease
Researchers at Sunnybrook Research Institute and the University of Toronto found that the rate of memory decline was slower in people with Alzheimer’s disease taking a specific class of anti-diabetic drug, known as a dipeptidyl peptidase-4 (DPP4) inhibitor.
Wednesday, July 22, 2020
Two Sunnybrook-led studies awarded funding through the Ontario COVID-19 Rapid Research Fund
The $20-million fund will support researchers working to find ways to prevent, detect and treat COVID-19.
Tuesday, July 14, 2020
Sunnybrook researchers have developed a new way to detect hearing loss in blood
Scientists demonstrated a way to detect hearing disorders using a simple blood test
Wednesday, July 8, 2020
First in Canada report: Promising results in deep brain stimulation trial for post-traumatic stress disorder
Serena Kelly, the first patient in Canada to participate in the trial, shares her story
Monday, June 29, 2020
Sunnybrook scientists receive $5.5M in CIHR funding for COVID-19 research
Three projects led by Sunnybrook researchers are part of a $109M federal investment in COVID-19 research over the next year
